ARK Genomic Revolution ETF
ARKG
3 hedge funds and large institutions have $603K invested in ARK Genomic Revolution ETF in 2015 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 0 closing their positions.
200% more funds holding
Funds holding: 1 → 3 (+2)
76% more capital invested
Capital invested by funds: $343K → $603K (+$260K)
2.59% more ownership
Funds ownership: 4.51% → 7.11% (+2.6%)
Top Buyers
| 1 |
Jane Street
New York
|
+$166K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$33.8K |
| 3 |
HFM
Hartford Financial Management
Hartford,
Connecticut
|
+$9.04K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Jane Street
New York
| $558K | +$166K | +8,347 | +46% |
|
|
2
UBS Group
Zurich,
Switzerland
| $36K | +$33.8K | +1,699 | New |
|
|
HFM
3
Hartford Financial Management
Hartford,
Connecticut
| $9K | +$9.04K | +455 | New |
|
ARKG Hedge Fund Activity: Q4 2015 in Review
3 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in ARK Genomic Revolution ETF (ARKG) for Q4 2015, worth a combined $603K — up 76% from $343K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new ARKG positions and 0 closed out — a net gain of 2 holders — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Jane Street, adding an estimated $166K.
- 3 institutional investors held ARK Genomic Revolution ETF (ARKG) as of Q4 2015, up from 1 in Q3 2015.
- Funds reported $603K of ARK Genomic Revolution ETF stock for Q4 2015, up 76% quarter-over-quarter.
- 2 funds opened new ARK Genomic Revolution ETF positions in Q4 2015 and 0 closed out, a net change of +2 holders.
- The largest ARK Genomic Revolution ETF buyer in Q4 2015 was Jane Street, an estimated $166K added.
Based on aggregated 13F filings for Q4 2015.